Aequus Pharmaceuticals Inc (AQS.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 50 | 170 | 250 | 2,392 | 1,719 |
| Receivables | 58 | 32 | 310 | 941 | 780 |
| Inventories | 38 | 124 | 94 | 140 | 123 |
| Other current assets | 0 | 45 | 45 | 45 | 0 |
| TOTAL | $282 | $436 | $903 | $3,593 | $2,768 |
| Non-Current Assets | |||||
| PPE Net | 518 | 651 | 789 | 242 | 366 |
| Other Non-Current Assets | 0 | 0 | 0 | 513 | 0 |
| TOTAL | $518 | $651 | $789 | $755 | $366 |
| Total Assets | $800 | $1,086 | $1,691 | $4,348 | $3,135 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 6,029 | 4,370 | 2,000 | 1,927 | N/A |
| Accounts payable and accrued liabilities | 543 | 274 | 88 | 157 | 161 |
| Accrued Expenses | 100 | 42 | 200 | 222 | 76 |
| TOTAL | $6,796 | $4,796 | $2,378 | $2,457 | $384 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 26 | 1,977 |
| TOTAL | $459 | $584 | $694 | $102 | $2,176 |
| Total Liabilities | $7,255 | $5,380 | $3,072 | $2,559 | $2,561 |
| Shareholders' Equity | |||||
| Common Shares | 23,991 | 23,991 | 23,991 | 23,991 | 21,172 |
| Retained earnings | -34,862 | -32,684 | -29,720 | -26,509 | -24,700 |
| Other shareholders' equity | 4,416 | 4,400 | 4,349 | 4,308 | 0 |
| TOTAL | $-6,455 | $-4,294 | $-1,380 | $1,789 | $574 |
| Total Liabilities And Equity | $800 | $1,086 | $1,691 | $4,348 | $3,135 |